---
title: Pharmacological blocking of microfibrillar-associated protein 4 reduces retinal
  neoangiogenesis and vascular leakage
date: '2025-01-26'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39863929/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250126170510&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Neovascular age-related macular degeneration and diabetic macular edema
  are leading causes of vision-loss evoked by retinal neovascularization and vascular
  leakage. The glycoprotein microfibrillar-associated protein 4 (MFAP4) is an integrin
  α(V)β(3/5/6) ligand present in the extracellular matrix. Single-cell transcriptomics
  reveal MFAP4 expression in cell-types in close proximity to vascular endothelial
  cells including choroidal vascular mural cells and retinal astrocytes and Müller
  ...
disable_comments: true
---
Neovascular age-related macular degeneration and diabetic macular edema are leading causes of vision-loss evoked by retinal neovascularization and vascular leakage. The glycoprotein microfibrillar-associated protein 4 (MFAP4) is an integrin α(V)β(3/5/6) ligand present in the extracellular matrix. Single-cell transcriptomics reveal MFAP4 expression in cell-types in close proximity to vascular endothelial cells including choroidal vascular mural cells and retinal astrocytes and Müller ...